miltefosine has been researched along with Cancer of Pancreas in 2 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, J | 1 |
Seupel, R | 1 |
Bruhn, T | 2 |
Feineis, D | 2 |
Kaiser, M | 2 |
Brun, R | 2 |
Mudogo, V | 2 |
Awale, S | 2 |
Bringmann, G | 2 |
Tshitenge, DT | 1 |
Schmidt, D | 1 |
Würthner, F | 1 |
2 other studies available for miltefosine and Cancer of Pancreas
Article | Year |
---|---|
Jozilebomines A and B, Naphthylisoquinoline Dimers from the Congolese Liana Ancistrocladus ileboensis, with Antiausterity Activities against the PANC-1 Human Pancreatic Cancer Cell Line.
Topics: Algorithms; Alkaloids; Animals; Antimalarials; Antineoplastic Agents, Phytogenic; Congo; Drug Screen | 2017 |
Ealamines A-H, a Series of Naphthylisoquinolines with the Rare 7,8'-Coupling Site, from the Congolese Liana
Topics: Animals; Antineoplastic Agents, Phytogenic; Antiprotozoal Agents; Caryophyllales; Drug Screening Ass | 2019 |